Walleye Capital’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-206,104
| Closed | -$8.17M | – | 3089 |
|
|
2024
Q1 | $8.17M | Sell |
206,104
-159,836
| -44% | -$6.34M | 0.01% | 304 |
|
|
2023
Q4 | $6.97M | Buy |
365,940
+179,667
| +96% | +$3.42M | 0.01% | 271 |
|
|
2023
Q3 | $2.13M | Buy |
186,273
+21,600
| +13% | +$247K | 0.01% | 634 |
|
|
2023
Q2 | $1.69M | Buy |
164,673
+130,556
| +383% | +$1.34M | 0.01% | 565 |
|
|
2023
Q1 | $263K | Buy |
+34,117
| New | +$263K | ﹤0.01% | 1222 |
|
|
2022
Q4 | – | Sell |
-71,355
| Closed | -$514K | – | 2726 |
|
|
2022
Q3 | $514K | Buy |
+71,355
| New | +$514K | 0.01% | 1037 |
|
|
2022
Q2 | – | Sell |
-41,746
| Closed | -$374K | – | 2723 |
|
|
2022
Q1 | $374K | Sell |
41,746
-68,353
| -62% | -$612K | 0.01% | 1136 |
|
|
2021
Q4 | $1.53M | Buy |
+110,099
| New | +$1.53M | 0.05% | 390 |
|